Page last updated: 2024-10-24

atrial septum development

Definition

Target type: biologicalprocess

The progression of the atrial septum over time, from its initial formation to the mature structure. [GOC:mtg_heart]

The atrial septum, a crucial structure separating the left and right atria of the heart, undergoes a complex developmental process. Its formation is essential for preventing mixing of oxygenated and deoxygenated blood, a critical step in proper fetal circulation. The development of the atrial septum is characterized by the interplay of multiple cellular events, including proliferation, migration, and differentiation, driven by intricate signaling pathways.

The process initiates with the formation of the septum primum, a crescent-shaped tissue that grows from the dorsal roof of the primitive atrium. This structure is initially attached to the endocardial cushions, serving as a temporary barrier between the atria. As the septum primum grows towards the ventricular septum, it gradually reduces the opening known as the ostium primum, leading to a separation of the atria.

Concurrently, a second structure, the septum secundum, develops adjacent to the septum primum, forming a larger, crescent-shaped flap that partially overlaps the ostium primum. This overlapping arrangement creates an opening known as the foramen ovale, facilitating the passage of blood from the right to the left atrium, bypassing the fetal lungs.

As the septum primum continues to grow and eventually fuses with the endocardial cushions, the ostium primum closes. The foramen ovale, however, remains open during fetal development, allowing the passage of oxygenated blood from the placenta directly to the systemic circulation. This shunt is crucial for bypassing the non-functional fetal lungs.

After birth, the increased pressure in the left atrium forces the septum primum against the septum secundum, effectively closing the foramen ovale and establishing the definitive separation between the atria. This closure is usually permanent, although a small residual opening, called the fossa ovalis, may remain.

The development of the atrial septum is a precise and complex process, intricately regulated by a diverse array of genetic and molecular factors. Any disruption in this delicate balance can lead to congenital heart defects, including atrial septal defects (ASDs), which can range in severity and require various treatments.

Overall, the formation of the atrial septum is a crucial step in the development of a functional heart, essential for maintaining the separation of oxygenated and deoxygenated blood streams and ensuring the appropriate circulation of blood throughout the body.'
"

Proteins (2)

ProteinDefinitionTaxonomy
E3 ubiquitin-protein ligase Mdm2An E3 ubiquitin-protein ligase Mdm2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q00987]Homo sapiens (human)
Protein Mdm4A protein Mdm4 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15151]Homo sapiens (human)

Compounds (19)

CompoundDefinitionClassesRoles
catecholcatecholsallelochemical;
genotoxin;
plant metabolite
gossypolGossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.
quinone1,4-benzoquinone : The simplest member of the class of 1,4-benzoquinones, obtained by the formal oxidation of hydroquinone to the corresponding diketone. It is a metabolite of benzene.

benzoquinone : The simplest members of the class of benzoquinones, consisting of cyclohexadiene which is substituted by two oxo groups.

quinone : Compounds having a fully conjugated cyclic dione structure, such as that of benzoquinones, derived from aromatic compounds by conversion of an even number of -CH= groups into -C(=O)- groups with any necessary rearrangement of double bonds (polycyclic and heterocyclic analogues are included).
1,4-benzoquinonescofactor;
human xenobiotic metabolite;
mouse metabolite
vorinostatvorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
dicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
apomorphineApomorphine: A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.aporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug
cytarabinebeta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside
antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
nutlin 3stilbenoid
nutlin 2
nutlin 1nutlin 1: an MDM2 antagonist; structure in first source
nutlin-3anutlin 3: an MDM2 antagonist; structure in first sourcestilbenoid
MI-63MI-63 : An azaspiro compound resulting from the formal fusion of position 3 of 6-chloro-oxindole with position 3 of (2R,3SS5S)-3-(3-chloro-2-fluorophenyl)-5-(2,2-dimethylpropyl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-2-carboxamide. It is a potent inhibitor of the MDM2-p53 interaction.azaspiro compound;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
oxindoles;
pyrrolidines;
secondary carboxamide
apoptosis inducer
nutlin-3bNutlin;
piperazinone
anticoronaviral agent
pb 12
spautin-1
nvp-cgm097NVP-CGM097: an MDM2 and HDM2 inhibitor; structure in first source
rg7388RG7388: structure in first source
sar405838SAR405838: an inhibitor of the interaction of MDM2 and p53; has antineoplastic activity; structure in first source
rg7112
amg 232